After Its 1,500% Jump, Is It Time to Sell Vaxart Stock?

Vaxart (NASDAQ: VXRT) was a micro-cap stock at the beginning of 2020. Because of the coronavirus pandemic and market optimism about Vaxart's oral vaccine platform, the stock took off last year, running up 15 times in value. Is it still a buy, or are there warning signs?

In a Motley Fool Live segment recorded on Jan. 15, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Taylor Carmichael discuss Vaxart and how the stock might do in 2021.  

Continue reading

Source Fool.com